NFE2L2 and endothelial dysfunction: Interestingly, DMB treatment restored nrf2 levels and downstream antioxidant enzymes (Figure 5E), suggesting nfr2 downregulation linked to plasma TMAO levels, which could be partially involved in the endothelial dysfunction induced by IMQ.